Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Immune Characteristics Associated with Lymphomatoid Granulomatosis and Outcome Following Treatment with Interferon-Alpha

Kieron Dunleavy, MD, Pratip Chattopadhyay, PhD, Junichi Kawada, Sara Calattini, Emma Gostick, PhD, David Price, MD, PhD, Mario Roderer, PhD, Jeffrey Cohen, MD, Nicole Grant, MPH, Stefania Pittaluga, MD, John E Janik, MD, Elaine S Jaffe, MD, Wyndham H. Wilson, MD, PhD

Blood (2010) 116 (21): 963.

https://doi.org/10.1182/blood.V116.21.963.963

Published: 2010

Journal Articles

Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL).

Kieron Dunleavy, MD, Stefania Pittaluga, MD, Kevin Tay, MD, Nicole Grant, MPH, Clara C Chen, MD, Margaret Shovlin, RN, Seth Steinberg, PhD, Louis M Staudt, MD, PhD, Elaine S Jaffe, MD, John E Janik, MD, Wyndham H Wilson, MD, PhD

Blood (2009) 114 (22): 106.

https://doi.org/10.1182/blood.V114.22.106.106

Published: 2009

Journal Articles

Gray Zone Lymphomas: Clinical and Histological Characteristics and Treatment with Dose-Adjusted-EPOCH-R

Kieron Dunleavy, MD, Stefania Pittaluga, MD, PhD, Nicole Grant, MPH, Seth Steinberg, PhD, Margaret Shovlin, RN, Kevin Tay, MD, John E. Janik, MD, Elaine S. Jaffe, M.D., Wyndham H. Wilson, MD, PhD

Blood (2008) 112 (11): 3590.

https://doi.org/10.1182/blood.V112.11.3590.3590

Published: 2008

Journal Articles

Long-Term Outcome of AIDS-Related Lymphoma Treated with Abbreviated Cycles of EPOCH-RR: A Prospective Study of 40 Patients

Kieron Dunleavy, MD, Richard Little, MD, Alan S. Wayne, MD, Nicole Grant, MPH, Stefania Pittaluga, MD, PhD, Elaine S. Jaffe, MD, Seth Steinberg, PhD, Robert Yarchoan, MD, PhD, Jorge A. Carrasquillo, MD, John E. Janik, MD, Wyndham H. Wilson, MD, PhD

Blood (2008) 112 (11): 3606.

https://doi.org/10.1182/blood.V112.11.3606.3606

Published: 2008

Journal Articles

Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome May Be Significantly Improved by the Addition of Rituximab to Dose-Adjusted (DA)-EPOCH and Obviates the Need for Radiation: Results from a Prospective Study of 44 Patients.

Kieron Dunleavy, MD, Stefania Pittaluga, MD, John Janik, MD, Nicole Grant, MPH, Margaret Shovlin, RN, Seth Steinberg, PhD, Mark Raffeld, MD, Louis Staudt, MD, PhD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, PhD

Blood (2006) 108 (11): 209.

https://doi.org/10.1182/blood.V108.11.209.209

Published: 2006

Journal Articles

DA-EPOCH-R Is Highly Effective in Both BCL-6+ and BCL-6− Untreated De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Study Update and Analysis of Survival Outcomes for Multiple Biomarkers.

Wyndham H. Wilson, MD, PhD, Kieron Dunleavy, MD, Stefania Pittaluga, MD, Nicole Grant, MPH, Margaret Shovlin, RN, Seth Steinberg, PhD, Mark Raffeld, MD, Louis Staudt, MD, PhD, Elaine S. Jaffe, MD, John Janik, MD

Blood (2006) 108 (11): 206.

https://doi.org/10.1182/blood.V108.11.206.206

Published: 2006

Journal Articles

Novel Treatment of Burkitt Lymphoma with Dose-Adjusted EPOCH-Rituximab: Preliminary Results Showing Excellent Outcome.

Kieron Dunleavy, MD, Stefania Pittaluga, MD, John Janik, MD, Nicole Grant, MPH, Margaret Shovlin, RN, Richard Little, MD, Robert Yarchoan, MD, Seth Steinberg, PhD, Elaine S. Jaffe, MD, Wyndham H. Wilson, MD, PhD

Blood (2006) 108 (11): 2736.

https://doi.org/10.1182/blood.V108.11.2736.2736

Published: 2006

Journal Articles

Abbreviated Treatment with EPOCH-Rituximab and HAART Suspension Is Highly Effective in AIDS-Related Lymphoma (ARL).

Kieron Dunleavy, MD, Alan S. Wayne, MD, Richard Little, MD, Nicole Grant, MPH, Seth Steinberg, PhD, Elaine S. Jaffe, MD, Stefania Pittaluga, MD, Robert Yarchoan, MD, Jorge Carrasquillo, MD, John Janik, MD, Wyndham H. Wilson, MD, PhD

Blood (2006) 108 (11): 2740.

https://doi.org/10.1182/blood.V108.11.2740.2740

Published: 2006

Journal Articles

A Pilot Trial of Campath-1H and Dose-Adjusted EPOCH in CD52-Expressing Aggressive T-Cell Malignancies.

John E. Janik, MD, Kieron Dunleavy, MD, Stefania Pittaluga, MD, Elaine S. Jaffe, MD, Nicole Grant, MPH, Margaret Shovlin, Maryalice Stetler-Stevenson, MD, Wyndham H. Wilson, MD

Blood (2005) 106 (11): 3348.

https://doi.org/10.1182/blood.V106.11.3348.3348

Published: 2005

NARROW

Immune Characteristics Associated with Lymphomatoid Granulomatosis and Outcome Following Treatment with Interferon-Alpha

Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL).

Gray Zone Lymphomas: Clinical and Histological Characteristics and Treatment with Dose-Adjusted-EPOCH-R

Long-Term Outcome of AIDS-Related Lymphoma Treated with Abbreviated Cycles of EPOCH-RR: A Prospective Study of 40 Patients

Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome May Be Significantly Improved by the Addition of Rituximab to Dose-Adjusted (DA)-EPOCH and Obviates the Need for Radiation: Results from a Prospective Study of 44 Patients.

DA-EPOCH-R Is Highly Effective in Both BCL-6+ and BCL-6− Untreated De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Study Update and Analysis of Survival Outcomes for Multiple Biomarkers.

Novel Treatment of Burkitt Lymphoma with Dose-Adjusted EPOCH-Rituximab: Preliminary Results Showing Excellent Outcome.

Abbreviated Treatment with EPOCH-Rituximab and HAART Suspension Is Highly Effective in AIDS-Related Lymphoma (ARL).

A Pilot Trial of Campath-1H and Dose-Adjusted EPOCH in CD52-Expressing Aggressive T-Cell Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only